Medical gaslighting and diagnostic delay statistics: how long women wait to be believed

She had kept a pain diary for three years before anyone ordered imaging that mattered. Severe dysmenorrhea since her teens. Two emergency visits labeled "anxiety." One primary-care note that said "possible IBS, reassure." When laparoscopy finally showed deep endometriosis, she cried. Part of it was relief. The other part was anger at how long it had taken to be believed.

Patients call this medical gaslighting: symptoms minimized as stress, weight, hormones, or "just periods" while the diagnostic clock keeps running. Clinicians often frame the same encounters as uncertainty. Both readings can be true. The numbers still show a pattern: women report dismissal more often than men, and for several conditions that hit women hardest, time from first symptoms to a correct diagnosis stretches into years. Below are the citable figures: survey rates, delays by condition, heart-attack misdiagnosis risk and sex differences in emergency pain care.

Condition	Delay measure	Value	Source
Endometriosis (U.S.)	Mean symptom onset → diagnosis	4.4 years	Soliman et al., 2017
Endometriosis (global)	Average time to diagnosis	4-12 years	WHO fact sheet
Endometriosis (Austria/Germany)	Median diagnostic time	10.4 years	Hudelist et al., via Li 2025 review
Endometriosis (USA and UK, older series)	Mean diagnostic time (combined sample)	9.41 years	Hadfield et al., 1996 (via Li 2025)
Systemic lupus erythematosus	Mean symptom → diagnosis	47 months	Kernder et al., 2021 (n=585)
Fibromyalgia (multi-country survey)	Mean time after first physician visit	2.3 years	Choy et al., 2010
Fibromyalgia (primary-care cohort)	Mean total time to diagnosis	6.42 years	Gendelman et al., 2018

Sources: Soliman et al. 2017; WHO Endometriosis fact sheet; Li et al. 2025; Kernder et al. 2021; Choy et al. 2010; Gendelman et al. 2018. Delay definitions vary (patient vs. provider vs. total time).

Experience (past 2 years)	Women	Men	Source
Doctor dismissed concerns	29%	21%	KFF 2022
Provider did not believe patient was telling the truth	15%	12%	KFF 2022
Provider assumed something without asking	19%	16%	KFF 2022
At least one listed negative experience	38%	32%	KFF 2022
Treated unfairly or with disrespect	23%	18%	KFF 2024
At least one negative experience (women only, 2024 items)	34%	-	KFF 2024

Source: KFF Women's Health Survey 2022 and 2024. Nationally representative adults ages 18-64 with a provider visit in the past two years. Item wording differs slightly by wave.

Dismissed concerns: what surveys measure

Medical gaslighting is a patient term, not a billing code. The cleanest U.S. population data come from KFF's Women's Health Surveys, which ask about concrete experiences rather than the word itself.

In the 2022 survey, among women ages 18-64 who had seen a provider in the past two years, 29% said their doctor had dismissed their concerns, versus 21% of men. Fifteen percent of women said a provider did not believe they were telling the truth. Nineteen percent said a doctor assumed something about them without asking, and 13% said a provider suggested they were personally to blame for a health problem. Overall, 38% of women reported at least one of those negative experiences, compared with 32% of men. The eight-point sex gap on dismissal is not enormous, but it is consistent.

The 2024 KFF wave (5,055 women and 1,191 men ages 18-64) used a slightly different battery. One in three women (34%) reported at least one negative experience. One in five (20%) said a provider ignored a direct request or question. One in ten said a provider refused pain medication they thought they needed. Separately, 23% of women said staff or a provider treated them unfairly or with disrespect, versus 18% of men. Weight was the most commonly named reason (15% of women); age and/or gender by 9%; race by 7% of women overall and 19% of Black women.

None of this proves intent. Survey items capture patient perception, and perception still predicts behavior. People who feel dismissed skip follow-up and sometimes stop seeking care for symptoms that turn out to be serious. That is how a single bad appointment stretches into a multi-year diagnostic delay.

Endometriosis: years of waiting

If one condition has become shorthand for diagnostic delay in women's health, it is endometriosis. WHO estimates that endometriosis affects about 10% of reproductive-age women worldwide (roughly 190 million people) and states that the average time to diagnosis is between 4 and 12 years. Country, study design, and whether delay is counted from first symptom or first consultation all move the number.

The most-cited U.S. figure is 4.4 years. Soliman, Fuldeore, and Snabes surveyed 638 U.S. women and reported a mean of 4.4 years from symptom onset to diagnosis (Journal of Women's Health, 2017). Younger women waited longer. Seeing an obstetrician-gynecologist rather than a non-specialist shortened the path. That figure is a measured average in one national sample, not a biological constant. It is still far too long.

International series often look worse. A 2025 systematic review by Li, Feng, and Ye (Frontiers in Medicine) put Austria and Germany at a median of 10.4 years and Hadfield and colleagues' older combined USA/UK sample at a mean of 9.41 years (11.73 years in the USA and 7.96 years in the UK in the primary Hadfield survey), against the shorter U.S. Soliman estimate. De Corte and colleagues' 2024 literature review found published diagnosis times ranging from 0.3 to 12 years depending on definition and geography. Symptoms get normalized as "bad periods." Menstrual stigma delays care-seeking. Provider misdiagnosis and non-specific pathways add years on top.

For prevalence and treatment, including racial disparities, see our review of endometriosis diagnosis and treatment statistics. Patients tracking irregular bleeding while they wait can use our period calculator and ovulation calculator to document patterns. A paper trail is not a diagnosis, but it is harder to dismiss than a vague recollection of "bad months."

Autoimmune disease and chronic pain delays

Autoimmune disease is another place where sex ratio and delay collide. NIH's Office of Autoimmune Disease Research states that about 8% of the U.S. population lives with an autoimmune disease and that nearly 80% of people with an autoimmune disease are women.

Systemic lupus erythematosus has the cleanest delay-plus-outcome data. Kernder and colleagues analyzed Germany's LuLa cohort (n = 585) and found a mean of 47 months between first symptoms and SLE diagnosis. Longer time to diagnosis tracked with higher disease activity, more damage, more fatigue, and lower quality of life after adjustment for age, disease duration, and sex. Waiting was not just unpleasant; it tracked with worse disease burden.

Kernder also cites a UK study of 121 SLE patients in which 70% received another diagnosis first, with a median of ten consultations and three different doctors before SLE was confirmed. Mitchell's 2024 review in the Journal of Family Medicine and Primary Care summarizes the broader literature as roughly 3 to 5 years from onset to diagnosis. The data vary by country and era. The direction is stable: lupus is often recognized late, and late recognition is associated with more damage.

Fibromyalgia shows a similar multi-year path. Choy and colleagues' multi-country survey (BMC Health Services Research, 2010) found patients waited a mean of 11.1 months after symptoms began before seeing a physician, then spent a mean of 2.3 years and saw 3.7 different physicians before diagnosis. Eighty-four percent of respondents were women. Gendelman and colleagues reported a mean total time to diagnosis of 6.42 years in primary-care data (a different definition: total time from symptoms, not time after first visit). Even so, it was a long wait. Our reviews of autoimmune disease in women and fibromyalgia statistics cover prevalence; the point here is that the delay is measured and large enough to change disease course.

Heart attack misdiagnosis

Diagnostic delay is not only a chronic-disease problem. In acute coronary care, a wrong initial label can cost hours patients do not have.

UK research using the Myocardial Ischaemia National Audit Project (MINAP) remains the cleanest large sex comparison. University of Leeds investigators analyzed more than 564,000 heart-attack cases over nine years. British Heart Foundation reporting on that work stated that women had about a 50% higher chance than men of receiving an incorrect initial diagnosis. For STEMI, women had a 59% greater chance of initial misdiagnosis; for NSTEMI, 41%. Nearly one-third of patients overall had an initial diagnosis that differed from the final one. Misdiagnosed patients, women and men, had about a 70% higher 30-day mortality risk than those whose initial and final diagnoses matched.

Those percentages are relative risk of a wrong first label, not the absolute share of women sent home undiagnosed. Relative risk of this size in a national registry is still hard to shrug off. Classic teaching still overweights the middle-aged man with crushing chest pain; when women present with nausea, jaw pain, or fatigue without dramatic chest pressure, the wrong category is more available. And more dangerous. For broader cardiac risk data, see heart disease statistics in women.

Pain is treated differently

Dismissal of women's symptoms often shows up first as undertreated pain.

Chen and colleagues (Academic Emergency Medicine, 2008) studied emergency patients with acute abdominal pain. Women who received analgesia waited longer than men: median 65 minutes versus 49 minutes, a 16-minute difference (95% CI 3.5-33). The paper is older and still among the most-cited sex-disparity findings in emergency pain care.

The 2024 PNAS analysis by Guzikevits and colleagues is larger. Across ED discharge notes from Israel and the United States (N = 21,851 pain visits), female patients were less likely than male patients to receive pain-relief prescriptions: 38% versus 47% in the primary Israeli dataset, even after adjustment for reported pain scores and other variables tied to patients, physicians and the ED. The gap appeared for opioids and nonopioids, and among male and female physicians. Female patients' pain scores were about 10% less likely to be recorded by nurses (37% vs. 41%), and female patients spent an additional 30 minutes in the ED (mean 4.87 vs. 4.42 hours). A vignette experiment in the same paper found nurses judged female patients' pain as less intense than male patients' pain.

Earlier ED studies are not perfectly consistent; some found smaller or null differences. The 2024 analysis is the strongest recent evidence that undertreatment of women's pain still operates at scale. Combined with KFF's finding that 1 in 10 women report being refused pain medication they thought they needed, the pattern is hard to treat as anecdote.

Who is dismissed most

Gender is not the only axis. In KFF 2022 data, 36% of women with a disability or ongoing health condition reported dismissed concerns, versus 22% of women without. More than four in ten women ages 18-35 (46%), uninsured women (46%), women on Medicaid (44%), and women with a disability or ongoing condition (45%) reported at least one negative interaction in the past two years.

The 2024 survey sharpened that picture. About half of LGBT+ women (51%) and nearly half of women who identify as disabled (47%) reported a negative provider experience. Black women (26%) and Hispanic women (25%) were somewhat more likely than White women (21%) to report unfair or disrespectful treatment; one in five Black women named race as the reason.

These numbers rhyme with disparities we document elsewhere: Black maternal health outcomes, disability and women's healthcare access, and broader healthcare access gaps among U.S. women. Younger women also report more negative interactions. That matters because endometriosis, autoimmune disease and fibromyalgia often begin when symptoms are easiest to reframe as stress or "normal periods."

Group	Measure	Rate
Women overall (2024)	Any of five negative experiences	34%
LGBT+ women (2024)	Any negative experience	51%
Women with disabilities (2024)	Any negative experience	47%
Women ages 18-35 (2022)	Any of listed negative interactions	46%
Women with disability/ongoing condition (2022)	Concerns dismissed	36%
Women without disability/ongoing condition (2022)	Concerns dismissed	22%

Source: KFF Women's Health Survey 2022 and 2024. Item sets differ by year; women ages 18-64 with a visit in the past two years.

What the delay costs

Delay is not a neutral waiting room. Kernder's lupus analysis linked longer time to diagnosis with worse activity and more damage. Fatigue was also worse. Endometriosis delay means years of untreated pain and higher infertility risk. Heart-attack misdiagnosis is associated with higher short-term mortality. Fibromyalgia delay means specialist shopping, unnecessary testing, and eroded trust.

There is a secondary harm surveys pick up better than claims data: patients learn not to report symptoms. After enough appointments that end in "it's stress," some women stop bringing new complaints until they are severe. That is rational adaptation to a system that has discounted their reports. It is also a setup for late presentation of disease.

What the evidence does not give us cleanly is a single national "gaslighting rate" or one average diagnostic delay across all of women's health. Conditions differ. Health systems differ. U.S. surveys are strong on patient experience and weaker on condition-specific timelines; some of the best delay cohorts are European. A responsible citation names the population, the year, and the exact measure.

For clinicians: take multi-year pain histories seriously; do not use "anxiety" as a final label when cardiac, gynecologic, or autoimmune workups are incomplete; record women's pain scores carefully; refer earlier when symptoms are recurrent and unexplained. For patients: document dates and failed treatments, ask for the differential out loud, and get a second opinion when the story and the label do not match. Our late period guide and cycle length calculator can help describe menstrual patterns while you wait for specialty care.

The woman with the three-year pain diary eventually got a name for her disease. She should not have needed a diary that long. These statistics exist so the next person, and the reporter writing about her, can point to a percentage, a year count and a primary source sitting next to both.

Frequently asked questions about medical gaslighting and diagnostic delay

What percentage of women say doctors dismiss their symptoms?

In the 2022 KFF Women's Health Survey, 29% of U.S. women ages 18-64 who had seen a provider in the past two years said a doctor dismissed their concerns, compared with 21% of men. Fifteen percent of women said a provider did not believe they were telling the truth. In the 2024 KFF wave, 34% of women reported at least one of several negative provider experiences.

How long does endometriosis take to diagnose?

Soliman and colleagues reported a mean of 4.4 years from symptom onset to diagnosis in a U.S. survey of 638 women (2017). The World Health Organization states that the average time to diagnosis is between 4 and 12 years globally. Older European series have reported medians near 10 years. Definitions and health systems explain much of the range.

Are women more likely to be misdiagnosed during a heart attack?

UK national registry research part-funded by the British Heart Foundation found women had about a 50% higher chance than men of an incorrect initial diagnosis after a heart attack, including a 59% greater chance for STEMI and 41% for NSTEMI. Misdiagnosed patients of either sex had roughly a 70% higher 30-day mortality risk than those with a consistent diagnosis.

How long does it take to diagnose lupus or other autoimmune disease?

In Germany's LuLa SLE cohort (Kernder et al., 2021), mean time from first symptoms to lupus diagnosis was 47 months. A UK series of 121 patients found 70% received another diagnosis first and needed a median of ten consultations with three doctors. Autoimmune disease overall disproportionately affects women: nearly 80% of people with autoimmune disease are women, per NIH ORWH/OADR.

Is women's pain treated differently in the emergency department?

Yes, in multiple studies. Chen et al. (2008) found women waited a median of 16 minutes longer than men for analgesia for acute abdominal pain. Guzikevits et al. (PNAS, 2024) found female patients less likely to receive pain prescriptions (38% vs. 47%) and about 30 minutes longer ED stays, with pain scores less often recorded.

Who faces the highest rates of negative healthcare experiences?

KFF data show elevated rates among younger women, women with disabilities, LGBT+ women, uninsured women, and women of color. In 2024, 51% of LGBT+ women and 47% of disabled women reported a negative provider experience. In 2022, 36% of women with a disability or ongoing condition said their concerns were dismissed, versus 22% of other women.